摘要:
The present invention relates, in general, to thymic microenvironment and, in particular, to a method of producing a thymic microenvironment. The invention further relates to a method of treating congenital and acquired immunodeficiencies using a thymic microenvironment produced in vitro. Included in acquired immunodeficiencies are syndromes seen in malignant and autoimmune diseases as well as traditional T cell immunodeficiency diseases such as occurs in AIDS.
摘要:
The present invention relates, in general, to CD6 and, in particular, to a CD6 ligand present on the surface of thymic epithelial cells, monocytes, activated T cells and a variety of other cell types. The invention further relates to methods of inhibiting the interaction of CD6 and the CD6 ligand, and to methods of screening compounds for their ability to inhibit that interaction. The invention also relates to antibodies, and binding fragments thereof, specific for CD6 ligand.
摘要:
L'invention concerne des préparations immunogènes de peptides comprenant des séquences d'acides aminés correspondant à des déterminants antigéniques de la glycoprotéine d'enveloppe de HTLV-I ou HTLV-II couplés de manière covalente, directement ou par l'intermédiaire d'une molécule d'espacement, à des molécules porteuses permettant la vaccination de mammifères. L'invention concerne également l'utilisation desdits peptides dans des méthodes de diagnostic.
摘要:
The present invention relates, in general, to human immunodeficiency virus (HIV), and, in particular, to a vaccine for HIV-1, comprising synthetic V3 glycopeptides, and to methods of making and using same.
摘要:
The present invention relates, in general, to human immunodeficiency virus (HIV), and in particular to a vaccine for HIV-1 and to methods of making and using same.
摘要:
The present invention relates, in general, to HIV-1 and, in particular, to a molecular clone of HIV- 1. The invention further relates to methods of inducing an immune response to HIV-1 in a patient and to immunogens suitable for use in such methods. The invention also relates to anti-HIV-1 antibodies and to methods of using same to prevent or treat HIV-infection.